Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by photobiomodulation induced by 670 nm light

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Muili, Kamaldeen A ^a,b   Gopalakrishnan, Sandeep ^a   Meyer, Stacy L ^a   Eells, Janis T ^a   Lyons, Jeri Anne ^a  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE;

ALLERGIC GLOMERULONEPHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; FEMALE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PHOTOBIOMODULATION; PHOTOTHERAPY; UPREGULATION; ALLERGIC ENCEPHALOMYELITIS; ANIMAL; BLOOD; C57BL MOUSE; COMPARATIVE STUDY; DISEASE COURSE; EVALUATION; INFRARED RADIATION; LIGHT; METHODOLOGY; PATHOLOGY; PHOTOBIOLOGY; TIME;

MUS;

ANIMALS; CYTOKINES; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INFLAMMATION MEDIATORS; INFRARED RAYS; LIGHT; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; PHOTOBIOLOGY; PHOTOTHERAPY; TIME FACTORS;

EID: 84856193459     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030655     Document Type: Article

References (77)

1. Bjartmar C, Trapp BD, (2001) Axonal Injury in Multiple Sclerosis. In: Cook SD, editors. Handbook of Multiple Sclerosis New York Marcel Dekker, Inc pp. 325-345.
2. Dutta R, McDonough J, Yin X, Peterson J, Chang A, et al. (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclersosis patieints. Annals of Neurology 59: 478-489.
3. Dutta R, Trapp BD, (2007) Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 68: S22-31; discussion S43-54.
4. Duda PW, Schmied MC, Cook SL, Krieger JI, Hafler DA, (2000) Glatiramer acetate (Copaxone) induces degenerate Th2-polarized immune responses in patients with multiple sclerosis. Journal of Clinical Investigation 105: 967-976.
5. Johnson KP, (2007) Natalizumab (Tysabri) treatment for relapsing multiple sclerosis. Neurologist 13: 182-187.
6. Lou J, Gasche Y, Zheng L, Giroud C, Morel P, et al. (1999) Interferon-beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer. Laboratory Investigation 79: 1015-1025.
7. Prinz M, Schmidt H, Mildner A, Knobeloch KP, Hanisch UK, et al. (2008) Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system.[see comment]. Immunity 28: 675-686.
8. Croxford AL, Kurschus FC, Waisman A, (2011) Mouse models for multiple sclerosis: historical facts and future implications. Biochimica et Biophysica ACTA 1812: 177-183.
9. Qi X, Lewin AS, Sun L, Hauswirth WW, Guy J, (2006) Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis. Journal of Biological Chemistry 281: 31950-31962.
10. Qi X, Lewin AS, Sun L, Hauswirth WW, Guy J, (2007) Suppression of mitochondrial oxidative stress provides long-term neuroprotection in Experimental Autoimmune Encephalomyelitis. Investigative Ophthalmology & Vision Science 48: 681-691.
11. Lyons RF, Abergel RP, White RA, Dwyer RM, Castel JC, et al. (1987) Biostimulation of wound healing in vivo by a helium-neon laser. Annals of Plastic Surgery 18: 47-50.
12. Whelan HT, Buchmann EV, Dhokalia A, Kane MP, Whelan NT, et al. (2003) Effect of NASA light-emitting diode irradiation on molecular changes for wound healing in diabetic mice. Journal of Clinical Laser Medicine & Surgery 21: 67-74.
13. Whelan HT, Smits RL, Buchmann EV, Whelan NT, Turner SG, et al. (2001) Effect of NASA light-emitting diode (LED) irradiation on wound healing. Journal of Clinical Laser Medicine & Surgery 19: 305-314.
14. Whelan HT, Connelly JF, Hodgson BD, Barbeau L, Post AC, et al. (2002) NASA light-emitting diodes for the prevention of oral mucositis in pediatric bone marrow transplant patients. Journal of Clinical Laser Medicine & Surgery 20: 319-324.
15. Oron U, Yaakobi T, Oron A, Hayam G, Gepstein L, et al. (2001) Attenuation of infarct size in rats and dogs after myocardial infarction by low-energy laser irradiation. Lasers Surg Med 28: 204-211.
16. Oron U, Yaakobi T, Oron A, Mordechovitz D, Shofti R, et al. (2001) Low-energy laser irradiation reduces formation of scar tissue after myocardial infarction in rats and dogs. Circulation 103: 296-301.
17. Zhang R, Mio Y, Pratt PF, Lohr N, Warltier DC, et al. (2009) Near infrared light protects cardiomyocytes from hypoxia and reoxygenation injury by a nitric oxide dependent mechanism. Journal of Molecular Cellular Cardiology 46: 4-14.
18. DeSmet KD, Paz DA, Corry JJ, Eells JT, Wong-Riley MTT, et al. (2006) Clinical and experimental applications of NIR-LED photobiomodulation. Photomedicine and Laser Surgery 24: 121-128.
19. Eells JT, DeSmet KD, Kirk DK, Wong-Riley MT, Whelan HT, et al. (2008) Photobiomodulation in the treateatment of retinal injury and retinal degenerative diseases. In: Tata D, Waynant RW, editors. Light Activated Tissue Regeneration and Therapy New York Springer Publishing pp. 39-51.
20. Eells JT, Kirk DK, Cribb J, Valter K, DeSmet KD, et al. (2006) Near-Infrared Light Therapy for Retinitis Pigmentosa. Investigative Ophthalmology & Vision Science 47: E-Abstract 1022.
21. Eells JT, Whelan HT, Salomao S, Berezovsky A, Paula H, et al. (2004) 670 nm LED Treatment of Affected Carriers of the 11778 Leber's Hereditary Optic Neuropathy (LHON) Mutation in Brazil. Invest Ophthalmol Vis Sci 45: 828.
22. Ying R, Liang HL, Whelan HT, Eells JT, Wong-Riley MTT, (2008) Pretreatment with near-infrared light via light-emitting diode provides added benefit against rotenone and MPP+ induced neurotoxicity. Brain Research 1243: 167-173.
23. Liang HL, Whelan HT, Eells JT, Wong-Riley MT, (2008) Near-infrared light via light-emitting diode treatment is therapeutic against rotenone- and 1-methyl-4-phenylpyridinium ion-induced neurotoxicity. Neuroscience 153: 963-974.
24. Eells JT, Wong-Riley MTT, VerHoeve J, Henry MM, Buchman EV, et al. (2004) Mitochondrial Signal Transduction in Accelerated Wound and Retinal Healing by Near-Infrared Light Therapy. Mitochondrion 4: 559-567.
25. Hamblin MR, Demidova TN, (2006) Mechanisms of Low Level Light Therapy. Procedings of SPIE 6140: 614001.614001-614001.614012.
26. Wong-Riley MTT, Liang HL, Eells JT, Chance B, Henry MM, et al. (2005) Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: Role of cytochrome c oxidase. Journal of Biological Chemistry 280: 4761-4771.
27. Wong-Riley MTT, Bai X, Buchman E, Whelan HT, (2001) Ligh-emitting diode treatment reverses the effect of TTX on cytochrome oxidase in neurons. NeuroReport 12: 3033-3037.
28. Karu TI, Pyatibrat LV, Kalendo GS, (2004) Photobiological modulation of cell attachment via cytochrome c oxidase. Photochem Photobiol Sci 3: 211-216.
29. Albertini R, Villaverde AB, Aimbire F, Bjordal JM, Brugnera A, et al. (2008) Cytokine mRNA expression is decreased in the subplantar muscle of rat paw subjected to carrageenan-induced inflammation after low-level laser therapy. Photomedicine and Laser Surgery 26: 19-34.
30. Arany PR, Nayak RS, Halikerimath S, Limaye AM, Kale AD, et al. (2007) Activation of latent TGF-beta1 levels in laser-enhanced oral wound healing. Wound Repair & Regeneration 15: 866-874.
31. Sospedra M, Martin R, (2005) Immunology of Multiple Sclerosis. Annual Review of Immunology 23: 683-747.
32. Caminero A, Comabella M, Montalban X, (2011) Tumor necrosis factor alpha (TNF-α), anti-TNF-α and demyelination revisited: An ongoing story. Journal of Neuroimmunology 234: 1-6.
33. Schluesener HJ, Sobel RA, Linington C, Weiner HL, (1987) A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. Journal of Immunology 139: 4016-4021.
34. Genain CP, Nguyen M-H, Letvin NL, Pearl R, Davis RL, et al. (1995) Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. Journal of Clinical Investigation 96: 2966-2974.
35. Weber MS, Hemmer B, Cepok S, (2011) The role of antibodies in multiple sclerosis. Biochimica et Biophysica ACTA 1812: 239-245.
36. Craner MJ, Damarjian TG, Liu S, Hains BC, Lo AC, et al. (2005) Sodium channels contribute to microglia/macrophage activation and function in EAE and MS. Glia 49: 220-229.
37. Bauer J, Sminia T, Wouterlood FG, Dijkstra CD, (1994) Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis. Journal of Neuroscience Research 38: 365-375.
38. Hendriks JJA, de Vries HE, van der Pol SMA, van den Berg TK, van Tol EAF, et al. (2003) Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study. Biochemical Pharmacology 65: 877-885.
39. Andrews HE, Nichols PP, Bates D, Turnbull DM, (2005) Mitochondrial dysfunction plays a key role in progressive axonal loss in multiple sclerosis. Medical Hypotheses 64: 669-677.
40. Aharoni R, Eilam R, Domev H, Labunskay G, Sela M, et al. (2005) The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice. Procedings of the National Academy of Sciences 102: 19045-19050.
41. Hussein Y, Sanna A, Soderstrom M, Link H, Huang Y-M, (2001) Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis. Journal of Neuroimmunology 121: 102-110.
42. Stuve O, Dooley NP, Uhm JH, Antel JP, Williams G, et al. (1996) Interferon beta-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase-9. Annals of Neurology 40: 853-863.
43. Mitton D, Ackroyd R, (2008) A brief overview of photodynamic therapy in Europe. Photodiagnosis & Photodynamic Therapy 5: 103-111.
44. Ackroyd R, Kelty C, Brown N, Reed M, (2001) The history of photodetection and photodynamic therapy. Photochemistry & Photobiology 74: 656-669.
45. Cavaletti G, Perseghin P, Buscemi F, Dassi M, Oggioni N, et al. (2001) Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis. International Journal of Tissue Reactions 23: 21-31.
46. Chabannes D, Besnier DP, Esnault VLM, (2002) Photopheresis affects the course of experimental allergic encephalomyelitis in Lewis rat. Photodermatology, Photoimmunology & Photomedicine 18: 238-243.
47. Leong S, Chan AH, Levy JG, Hunt DW, (1996) Transcutaneous photodynamic therapy alters the development of an adoptively transferred form of murine experimental autoimmune encephalomyelitis. Photochemistry & Photobiology 64: 751-757.
48. el-Ghorr AA, Norval M, (1997) The role of interleukin-4 in ultraviolet B light-induced immunosuppression. Immunology 92: 26-32.
49. Vermeer BJ, Hurks M, (1994) The clinical relevance of immunosuppression by UV irradiation. Journal of Photochemistry & Photobiology B- Biology 24: 149-154.
50. Walterscheid JP, Nghiem DX, Ullrich SE, (2002) Determining the role of cytokines in UV-induced immunomodulation. Methods (Duluth) 28: 71-78.
51. Ullrich SE, Schmitt DA, (2000) The role of cytokines in UV-induced systemic immune suppression. Journal of Dermatological Science 23 (Suppl 1): S10-12.
52. Ullrich SE, Nghiem DX, Khaskina P, (2007) Suppression of an established immune response by UVA- critical role for mast cells. Photochemistry & Photobiology 83: 1095-1100.
53. Ullrich SE, McIntyre BW, Rivas JM, (1990) Suppression of the immune response to alloantigen by factors released from ultraviolet-irradiated keratinocytes. Journal of Immunology 145: 489-498.
54. Hauser SL, Weiner HL, Che M, Shapiro ME, Gilles F, et al. (1984) Prevention of experimental allergic encephalomyelitis (EAE) in the SJL/J mouse by whole body ultraviolet irradiation. Journal of Immunology 132: 1276-1281.
55. Shaw VE, Spana S, Ashkan K, Benabid A-L, Stone J, et al. (2010) Neuroprotection of Midbrain Dopaminergic Cells in MPTP-Treated Mice after Near-infrared Light Treatment. Journal of Comparative Neurology 518: 25-40.
56. Lampl Y, Zivin JA, Fisher M, Lew R, Welin L, et al. (2007) Infrared Laser Therapy for Ischemic Stroke: A New Treatment Strategy: Results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Stroke 38: 1843-1849.
57. Oron A, Oron U, Chen J, Eilam A, Zhang C, et al. (2006) Low-Level Laser Therapy Applied Transcranially to Rats After Induction of Stroke Significantly Reduces Long-Term Neurological Deficits. Stroke 37: 2620-2624.
58. Nathan C, (2003) Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. Journal of Clinical Investigation 111: 769-778.
59. Huang Y-Y, Chen AC-H, Carroll JD, Hamblin MR, (2009) Biphasic Dose Response in Low Level Light Therapy. Dose-Respone 7: 358-383.
60. Chung H, Dai T, Sharma SK, Huang YY, Caroll JD, et al. (2011) The Nuts and Bolts of Low-level Laser (Light) Therapy. Annals of Biomedical Engineering.
61. Poyton RO, Ball KA, (2011) Therapeutic photobiomodulation: nitric oxide and a novel function of mitochondrial cytochrome c oxidase. Discovery Medicine 11: 154-159.
62. Chen AC, Arany PR, Huang YY, Tomkinson EM, Sharma SK, et al. (2011) Low-level laser therapy activates NF-kB via generation of reactive oxygen species in mouse embyronic fibroblasts. PLoS ONE [Electronic Resource] 6: e22453.
63. Cross AH, Keeling RM, Goorha S, San M, Rodi C, et al. (1996) Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in adoptively-transferred murine EAE. Journal of Neuroimmunology 71: 145-153.
64. Cross AH, Misko TP, Lin RF, Hickey WF, Trotter JL, et al. (1994) Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. Journal of Clinical Investigation 93: 2684-2690.
65. Cross AH, Ramsbottom MJ, Lyons J-A, (2006) NOS2 regulates cytokine production and VLA-4 expression in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 173: 79-86.
66. Dalton DK, Wittmer S, (2005) Nitric-oxide-dependent and independent mechanisms of protection from CNS inflammation during Th1-mediated autoimmunity: evidence from EAE in iNOS KO mice. Journal of Neuroimmunology 160: 110-121.
67. Kahl KG, Schmidt HH, Jung S, Sherman P, Toyka KV, et al. (2004) Experimental autoimmune encephalomyelitis in mice wiht a targeted deletion of the inducible nitric oxide synthase gene: increased T-helper 1 response. Neuroscience Letters 358: 58-62.
68. Smith KJ, Lassmann H, (2002) The role of nitric oxide in multiple sclerosis. Lancet Neurology 1: 232-241.
69. Albarracin R, Eells JT, Valter K, (2011) Photobiomodulation Protects the Retina from Light-Induced Photoreceptor Degeneration. Invest Ophthalmol Vis Sci 52: 3582-3592.
70. Khalili K, White MK, Lublin F, Ferrante P, Berger JR, (2007) Reactivation of JC virus and development of PML in patients with multiple sclerosis. Neurology 68: 985-990.
71. Roberts JE, (2000) Light and Immunomodulation. Annals of the New York Academy of Sciences 917: 435-445.
72. Ribeiro MA, Albuquerque RL Jr, Ramalho LM, Pinheiro AL, Bonjardim LR, et al. (2009) Immunohistochemical assessment of myofibroblasts and lymphoid cells during wound healing in rats subjected to laser photobiomodulation at 660 nm. Photomedicine and Laser Surgery 27: 49-55.
73. Suryani S, Sutton I, (2007) An interferon-gamma-producing Th1 subset is the major source of IL17 in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 183: 96-103.
74. Waldburger KE, Hastings RC, Schaub RG, Goldman SJ, Leonard JP, (1996) Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interelukin-12. Preferential expansion of interferon-gamma-producing cells and increased expression of macrophage-associated inducible nitric oxide synthase as immunomodulatory mechanisms. American Journal of Pathology 148: 375-382.
75. Hickey WF, Hsu BL, Kimura J, (1991) T-lymphocyte entry into the central nervous system. Journal of Neuroscience Research 28: 254-260.
76. Male D, Pryce G, Hughes C, Lantos PL, (1990) Lymphocyte migration into Brain modelled in vitro: control by lymphocyte activation, cytokines, and antigen. Cellular Immunololgy 127: 1-11.
77. Fitzgerald M, Bartlett CA, Payne SC, Hart NS, Rodger J, et al. (2010) Near Infrared Light Reduces Oxidative Stress and Preserves Function in CNS Tissue Vulnerable to Secondary Degeneration Following Partial Transection of the Optic Nerve. Journal of Neurotrauma 27: 2107-2119.